CHRISTINE A. POON - Corporate Board Profile

NEUROCRINE BIOSCIENCES INC

Filing Date	Source Excerpt
2024-04-10	Christine A. Poon has served on the Board of Directors since July 2023. ... Ms. Poon was named Woman of the Year by the Healthcare Businesswomen’s Association in 2004 and named Business Leader of the Future by CNBC/Wall Street Journal in 2005. ... Upon her appointment to the Board, Ms. Poon did not immediately join any committees to ensure a smooth onboarding process and to provide the Board with an opportunity to evaluate her other time commitments. After a series of discussions with Ms. Poon over the course of several months and taking into account her exceptional experience and the Company’s evolving needs, Ms. Poon joined the Audit Committee and Nominating / Corporate Governance Committee in February 2024. ... For fiscal 2023, directors who are not employees of the Company earned a $60,000 annual cash retainer. ... In addition to the cash compensation set forth above, the Chair of the Audit Committee earned an additional $25,000 annual cash retainer, the Chair of the Compensation Committee earned an additional $20,000 annual cash retainer, and the Chair of the Nominating / Corporate Governance Committee earned an additional $15,000 annual cash retainer. Each other director who was a member of the Audit Committee, the Compensation Committee, the Nominating / Corporate Governance Committee earned an additional annual cash retainer of $12,000, $12,000, and $7,500, respectively, for each Committee on which she or he served. ... For fiscal 2023, on the date of the 2023 Annual Meeting of Stockholders, each continuing non-employee director received an annual equity award with an approximate grant date value of $400,000. ... Newly-appointed members of our Board of Directors received an initial equity award with an approximate grant value of $800,000 on their date of appointment. This initial equity award is comprised 100% of nonstatutory stock options, vests monthly over three years, and has a ten-year term. ... The following table sets forth the compensation earned for the fiscal year ended December 31, 2023 by the directors of the Company named below: ... Christine A. Poon $13,370 cash fees, $800,083 option awards, total $813,453.

Filing Date

Source Excerpt

2024-04-10

Christine A. Poon has served on the Board of Directors since July 2023. ... Ms. Poon was named Woman of the Year by the Healthcare Businesswomen’s Association in 2004 and named Business Leader of the Future by CNBC/Wall Street Journal in 2005. ... Upon her appointment to the Board, Ms. Poon did not immediately join any committees to ensure a smooth onboarding process and to provide the Board with an opportunity to evaluate her other time commitments. After a series of discussions with Ms. Poon over the course of several months and taking into account her exceptional experience and the Company’s evolving needs, Ms. Poon joined the Audit Committee and Nominating / Corporate Governance Committee in February 2024. ... For fiscal 2023, directors who are not employees of the Company earned a $60,000 annual cash retainer. ... In addition to the cash compensation set forth above, the Chair of the Audit Committee earned an additional $25,000 annual cash retainer, the Chair of the Compensation Committee earned an additional $20,000 annual cash retainer, and the Chair of the Nominating / Corporate Governance Committee earned an additional $15,000 annual cash retainer. Each other director who was a member of the Audit Committee, the Compensation Committee, the Nominating / Corporate Governance Committee earned an additional annual cash retainer of $12,000, $12,000, and $7,500, respectively, for each Committee on which she or he served. ... For fiscal 2023, on the date of the 2023 Annual Meeting of Stockholders, each continuing non-employee director received an annual equity award with an approximate grant date value of $400,000. ... Newly-appointed members of our Board of Directors received an initial equity award with an approximate grant value of $800,000 on their date of appointment. This initial equity award is comprised 100% of nonstatutory stock options, vests monthly over three years, and has a ten-year term. ... The following table sets forth the compensation earned for the fiscal year ended December 31, 2023 by the directors of the Company named below: ... Christine A. Poon $13,370 cash fees, $800,083 option awards, total $813,453.

PRUDENTIAL FINANCIAL INC

Filing Date	Source Excerpt
2020-03-26	Ms. Poon has served as Executive in Residence at the Max M. Fisher College of Business ... previously served as Dean and John W. Berry, Sr. Chair in Business.
2021-03-25	Ms. Poon has served as Executive in Residence at The Ohio State University ... previously Dean and Chair in Business ... Vice Chairman and Board member of Johnson & Johnson.
2022-03-24	Ms. Poon served as Executive in Residence at The Max M. Fisher College of Business ... served as Dean and Chair in Business at The Fisher College of Business ... served as Vice Chairman and Board Member of Johnson & Johnson.
2023-03-23	Ms. Poon served as Executive in Residence at The Max M. Fisher College of Business at The Ohio State University from 2015 until her retirement in 2020 and served as Professor of Management and Human Resources at The Fisher College of Business from October 2014 to September 2015.
2024-03-28	Ms. Poon served as Executive in Residence at The Max M. Fisher College of Business at The Ohio State University from 2015 until her retirement in 2020 and served as Professor of Management and Human Resources at The Fisher College of Business from October 2014 to September 2015. Ms. Poon previously served as Dean and John W. Berry, Sr. Chair in Business at The Fisher College of Business at The Ohio State University from April 2009 until October 2014.
2025-03-27	Ms. Poon served as Executive in Residence and Professor of Management and Human Resources at The Ohio State University, and held executive roles at Johnson & Johnson and Bristol-Myers Squibb.

REGENERON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2016-04-26	CHRISTINE A. POON, 63, has been a director of the Company since November 2010. Ms. Poon is an Executive-in-Residence in the Department of Management and Human Resources at The Max M. Fisher College of Business at The Ohio State University, where she served as Dean and the John W. Berry, Sr. Chair in Business from 2009 to 2014. Prior to joining Fisher, Ms. Poon spent eight years at Johnson & Johnson, most recently as vice chairman and worldwide chairman of pharmaceuticals. At Johnson & Johnson, she served on the company's board of directors and executive committee and was responsible for managing the pharmaceutical businesses of the company. Prior to joining Johnson & Johnson, Ms. Poon spent 15 years at Bristol-Myers Squibb Company, a global pharmaceutical company, where she held senior leadership positions including president of international medicines and president of medical devices. Ms. Poon serves on the boards of directors of Prudential Financial, Inc. and The Sherwin-Williams Company and the Supervisory Board of Royal Philips Electronics. Ms. Poon's extensive expertise in domestic and international business operations, including sales and marketing and commercial operations, and her deep strategic and operational knowledge of the pharmaceutical industry, led to the board's decision to nominate Ms. Poon for reelection to the board.
2017-04-25	Ms. Poon is an Executive-in-Residence in the Department of Management and Human Resources at The Max M. Fisher College of Business at The Ohio State University, where she served as Dean and the John W. Berry, Sr. Chair in Business from 2009 to 2014. ... Ms. Poon serves on the boards of directors of Prudential Financial, Inc. and The Sherwin-Williams Company and the Supervisory Board of Royal Philips Electronics. ... Ms. Poon was elected as Chairperson of the Compensation Committee effective April 1, 2016. ... Compensation of Directors: Christine A. Poon 2,101,585.
2018-04-23	CHRISTINE A. POON Director since: 2010 Age: 65 Independent Other Public Boards (Recent Service) Ms. Poon is an Executive-in-Residence in the Department of Management and Human Resources at The Max M. Fisher College of Business at The Ohio State University, where she served as Dean and the John W. Berry, Sr. Chair in Business from 2009 to 2014. Prior to joining Fisher, Ms. Poon spent eight years at Johnson & Johnson, most recently as vice chairman and worldwide chairman of pharmaceuticals. At Johnson & Johnson, she served on the company's board of directors and executive committee and was responsible for managing the pharmaceutical businesses of the company. Prior to joining Johnson & Johnson, Ms. Poon spent 15 years at Bristol-Myers Squibb Company, a global pharmaceutical company, where she held senior leadership positions including president of international medicines and president of medical devices. Ms. Poon serves on the boards of directors of Prudential Financial, Inc. and The Sherwin-Williams Company and the Supervisory Board of Royal Philips Electronics. Ms. Poon's extensive expertise in domestic and international business operations, including sales and marketing and commercial operations, and her deep strategic and operational knowledge of the pharmaceutical industry, led the board to conclude that Ms. Poon should serve as a director. Board and Committee Membership: Board of Directors, Compensation Committee (Chairperson), Corporate Governance and Compliance Committee. Compensation of Directors table shows $1,232,211 option awards and $85,000 fees earned in cash totaling $1,317,211.
2020-04-24	Ms. Poon is an Executive-in-Residence in the Department of Management and Human Resources at The Max M. Fisher College of Business at The Ohio State University, where she served as Dean and the John W. Berry, Sr. Chair in Business from 2009 to 2014. Prior to joining Fisher, Ms. Poon spent eight years at Johnson & Johnson, most recently as vice chairman and worldwide chairman of pharmaceuticals. At Johnson & Johnson, she served on the company9s board of directors and executive committee and was responsible for managing the pharmaceutical businesses of the company. Prior to joining Johnson & Johnson, Ms. Poon spent 15 years at Bristol-Myers Squibb Company, a global pharmaceutical company, where she held senior leadership positions including president of international medicines and president of medical devices. Ms. Poon serves on the boards of directors of Prudential Financial, Inc. and The Sherwin-Williams Company and the Supervisory Board of Royal Philips Electronics. Ms. Poon9s extensive expertise in domestic and international business operations, including sales and marketing and commercial operations, and her deep strategic and operational knowledge of the pharmaceutical industry, led to the board9s decision to nominate Ms. Poon for reelection to the board. Board and Committee Membership 62019 Attendance Board of Directors 6/6 Compensation Committee (Chairperson) 14/14 Corporate Governance and Compliance Committee 5/5 Director Compensation Christine A. Poon 2019 Total Compensation: $719,993
2022-04-21	Christine A. Poon Director since: 2010 Age: 69 Independent Board and Committee Membership–2021 Attendance Board of Directors: 9/9 Compensation Committee (Chair): 15/15 Corporate Governance and Compliance Committee: 5/5 Director Compensation Table: Christine A. Poon Total: 720,094
2023-04-21	CHRISTINE A. POON Director since: 2010 Age: 70 Independent Board and Committee Membership—2022 Attendance Board of Directors: 7/7 Compensation Committee (Chair): 12/12 Corporate Governance and Compliance Committee: 5/5 Regeneron Securities Beneficially Owned as of April 11, 2023 Common Stock: 790 Options: 62,894 RSUs: 1,153 ... The following table and explanatory footnotes provide information with respect to compensation paid to Ms. Poon for their service in 2022: Total: $720,029.
2024-04-25	Christine A. Poon - Director since 2010, Age 71. Lead Independent Director since June 2023. Chair of Compensation Committee. Compensation: $748,009.

SHERWIN WILLIAMS CO

Filing Date	Source Excerpt
2018-03-07	Christine A. Poon has served as Executive in Residence at The Max M. Fisher College of Business at The Ohio State University since September 2015. 2017 Director Compensation Table shows C. A. Poon total compensation as $296,233.
2019-03-06	Christine A. Poon has served as Executive in Residence at The Ohio State University ... Director of Sherwin-Williams since 2014 ... Chair of Compensation Committee, Audit Committee member ... 2018 Director Compensation Table shows Christine A. Poon total compensation $279,310.
2020-03-09	Christine A. Poon Executive in Residence, The Ohio State University Age: 67 Director since: 2014 Committees: Audit and Nominating and Corporate Governance (Chair). 2019 Director Compensation Table shows total compensation of $324,408.
2021-03-10	Christine A. Poon Executive in Residence, The Ohio State University Age: 68 Director since: 2014 Committees: Compensation and Management Development, Nominating and Corporate Governance 2020 Director Compensation Table: Total $291,825
2022-03-09	Christine A. Poon Retired, Former Vice Chairman, Johnson & Johnson Director since: 2014 Age: 69 Committees: Compensation Committee 2021 Director Compensation Table: Total $286,931
2023-03-08	Christine A. Poon Retired, Former Vice Chairman, Johnson & Johnson Director since: 2014 Age: 70 Committees: Compensation Committee. 2022 Director Compensation Table: Total $278,232.
2024-03-06	Retired, Former Vice Chairman, Johnson & Johnson